2m 2m 2m 2m 2m 2m 2m
VERA THERAPEUT-A (VERA)
NASDAQ
$30.51-$0.48 (-1.55%)
Price as of Oct 02, 2026 6:33 PM EDT- $2.2BMarket Cap
- 6.17%1-Year Change
- BiotechnologyIndustry
VERA THERAPEUT-A (VERA)
$30.51-$0.48 (-1.55%)
VERA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $30.99 | ||
Change | -$1.30 (-4.03%) | ||
Open | $32.14 | ||
High | $32.44 | ||
Low | $30.87 | ||
Previous Close | $32.29 | ||
Volume | 1,009,595 | ||
30-Day Average Volume | 2,465,515 | ||
1-Week Change | -7.05% | ||
1-Month Change | -9.47% | ||
1-Year Change | 6.17% | ||
3-Year Change | 126.04% | ||
5-Year Change | 70.46% | ||
Fundamentals | |||
Shares Outstanding | 72.1M | ||
Total Assets | $533.0M | ||
Market Cap | $2.2B | ||
Enterprise Value | $2.3B | ||
Period: QTR TTM FY | |||
Revenue | -$247,000.00 | ||
Net Income | -$109.5M | ||
Free Cash Flow | -$100.3M | ||
EBIT | -$109.5M | ||
EBITDA | -$109.3M | ||
Net Working Capital | $479.2M | ||
EPS | -$1.52 | ||
Enterprise Value/EBITDA | -21 | ||
Enterprise Value/Revenue | -9,148 | ||
P/B | 5 | ||
P/E | -20 | ||
PEG | -2 | ||
Price/Free Cash Flow | -22 | ||
Price/Operating Cash Flow | -22 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue